Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression.
Int Immunopharmacol
; 42: 130-138, 2017 Jan.
Article
in En
| MEDLINE
| ID: mdl-27912149
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Flavonoids
/
Origanum
/
Phosphatidylethanolamine Binding Protein
/
Chemical and Drug Induced Liver Injury
/
Glycosides
/
Anti-Inflammatory Agents
Type of study:
Prognostic_studies
Language:
En
Journal:
Int Immunopharmacol
Year:
2017
Type:
Article
Affiliation country:
China